Management of graft-versus-host disease
- 31 December 2000
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 14 (4), 190-204
- https://doi.org/10.1054/blre.2000.0137
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Practical considerations in the use of tacrolimus for allogeneic marrow transplantationBone Marrow Transplantation, 1999
- Tacrolimus vs. cyclosporine immunosuppression: Results in advanced-stage disease compared with historical controls treated exclusively with cyclosporineTransplantation and Cellular Therapy, 1999
- IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADEBritish Journal of Haematology, 1997
- The OcuBar Manifestations of Graft-Versus-Host DiseaseInternational Ophthalmology Clinics, 1997
- RISK FACTORS FOR ACUTE GRAFT-VERSUS-HOST DISEASE IN HISTOCOMPATIBLE DONOR BONE MARROW TRANSPLANTATIONTransplantation, 1991
- LONG-TERM CYCLOSPORIN THERAPY MAY DECREASE THE RISK OF CHRONIC GRAFT-VERSUS-HOST DISEASEBritish Journal of Haematology, 1990
- LOW-DOSE (ONE GRAY) TOTAL-LYMPHOID IRRADIATION FOR EXTENSIVE, DRUG-RESISTANT CHRONIC GRAFT-VERSUS-HOST DISEASETransplantation, 1990
- Successful Allogeneic Transplantation of T-Cell–Depleted Bone Marrow from Closely HLA-Matched Unrelated DonorsNew England Journal of Medicine, 1990
- Hemopoietic progenitor cell function after hla‐identical sibling bone marrow transplantation: Influence of chronic graft‐versus‐host diseaseThe International Journal of Cell Cloning, 1986
- Myasthenia Gravis after Bone-Marrow TransplantationNew England Journal of Medicine, 1983